In HR-MDS, high level of TGF-β from mesenchymal stem cells (MSCs) inhibits the normal function of B, T and NK cells and induces the proliferation of Treg cells, so as to promote the immunosuppressive microenvironment and development of disease (22). The gene discussed is TGFB1; the disease is myelodysplastic syndrome.